REPORT OF WEBINAR ON MSL – AMMIS

By Epainete Gawa / May 27, 2020 / Comments Off on REPORT OF WEBINAR ON MSL – AMMIS

As part of its annual activities, the French Association des Métiers Médicaux des Industries de Santé (AMMIS – French Association of Medical Professions in the Health Industries) organized on May 14, 2020 a webinar about the topic “Medical Science Liaison (MSL): evolution and expectations of the profession”. With the moderation of Dr Epaïnète GAWA, member…

Read More

Cancellation ICPM 2020

By Epainete Gawa / May 12, 2020 / Comments Off on Cancellation ICPM 2020

Based on the careful observation and analysis of the collected information related to the global COVID-19 pandemic, IFAPP decided to cancel ICPM 2020. In September 2020, we will finalise our schedule of the next ICPM to be held in 2022 based on the updated information of infection control and feasibility of a public meeting. We…

Read More

“New Trends of Research Ethics”

By Epainete Gawa / May 11, 2020 / Comments Off on “New Trends of Research Ethics”

The IFAPP Ethics Working Group (https://ifapp.org/working-groups/ethics-and-professionalism) is delighted to share with you the summary of the Presidential Symposium of the Japanese Society of Clinical Pharmacology and Therapeutics held in Tokyo on 4 December 2019 on the topic of “International Collaborative Research and New Trends of Research Ethics”. You can access the proceedings in the journal Rinsho…

Read More

XX ICPM and I SIMeF Conference

By Anna Rodet / April 22, 2020 / Comments Off on XX ICPM and I SIMeF Conference

Please mark in your calendar the dates of December 2-3-4, 2020: we do hope to see many of you at the Conference Center of Sapienza University in Rome

Read More

IFAPP Launched a “Company Page” on LinkedIn

By Anna Rodet / April 12, 2020 / Comments Off on IFAPP Launched a “Company Page” on LinkedIn

After a nice growth of the number of group members on LinkedIn IFAPP intends to reach out with its communications to more than the current group of 560 pharmaceutical medicine professionals. Maintaining the group status has a number of advantages, not the least that we know each other by name. It does, however, not allow…

Read More

New IFAPP Member Associations from Bulgaria and Turkey

By Anna Rodet / April 12, 2020 / Comments Off on New IFAPP Member Associations from Bulgaria and Turkey

On 24 March 2020 the IFAPP House of Delegates unanimously adopted the membership applications from BADI, the Bulgarian Association of Drug Information, and the Pharmaceutical Medicine Working Group of BIYILDER, the Biotechnological Drugs Society, Turkey. IFAPP extends a warm welcome and looks forward to closely cooperating with both societies.

Read More

COVID-19/SARS-CoV-2 Pandemic

By Anna Rodet / April 12, 2020 / Comments Off on COVID-19/SARS-CoV-2 Pandemic

Check out this article from the Faculty of Pharmaceutical Medicine, prepared by Dr. Penny Ward FFPM, detailing the current knowledge on SARS-CoV-2 and COVID-19 including the epidemiology of the outbreak, viral lifestyle and current treatment. https://www.fpm.org.uk/blog/covid-19-sars-cov-2-pandemic/

Read More

I am IFAPP: Brigitte Franke-Bray

By Anna Jurczynska / March 30, 2020 / Comments Off on I am IFAPP: Brigitte Franke-Bray

Why am I IFAPP? Why am I member of a National Member Association of IFAPP and also an Individual Affiliate? Over the course of my career, I have gained many years of experience in areas important to IFAPP: I have been a member of a Swiss Member Association since its inauguration and was a board…

Read More

IFAPP’s recommendation in combatting COVID-19

By Anna Rodet / March 24, 2020 / Comments Off on IFAPP’s recommendation in combatting COVID-19
Read More

FDA statement

By Anna Rodet / March 23, 2020 / Comments Off on FDA statement

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic

Read More